About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
22 09, 2025

7 Conditions Magnesium Can Help Treat and Prevent Naturally

By |2025-09-22T22:20:51+03:00September 22, 2025|Dietary Supplements News, News|0 Comments


Magnesium is a mineral that your body doesn’t produce naturally—you can only get it through food or supplements.

And it’s important to get enough, because magnesium is essential for proper bodily functioning. It supports processes like mineral absorption, energy production, muscle and nerve function, and DNA synthesis.

So how does that translate to better health? Here are seven conditions magnesium may help treat or prevent.

Magnesium acts as a vasodilator, meaning it widens the blood vessels, which can help lower blood pressure and reduce your risk for heart disease and stroke.

Magnesium only decreases blood pressure by a small amount, so people with high blood pressure (hypertension) may benefit from taking other blood pressure-lowering medications along with magnesium.

Consuming high amounts of magnesium is linked to a lower risk of diabetes, likely because magnesium can help metabolize glucose (sugar). Not having enough magnesium may also worsen insulin resistance, which can increase the risk of type 2 diabetes.

Magnesium is the main ingredient in many laxatives. Different types of magnesium are commonly used to treat constipation, including magnesium citrate, hydroxide, oxide, and sulfate salts.

The recommended starting dose for constipation is 400-500 milligrams per day, based on how well you respond. Drink plenty of water when taking magnesium for constipation.

Magnesium plays a role in creating and strengthening bones. People with low magnesium levels are at a higher risk of osteopenia (lower than normal bone density) and osteoporosis (the more advanced stage of osteopenia).

Magnesium helps reduce the risk of bone fractures and osteoporosis, especially in postmenopausal and older women.

Magnesium supplements may help reduce the frequency of migraines. It likely does this by lessening the constriction of blood vessels and neurotransmitters that cause migraines.

While it may reduce migraine frequency, it’s not clear if magnesium can actually prevent migraines.

Magnesium supplements may help ease stress and anxiety and treat symptoms of depression.

Research has found an association between low magnesium levels and mental health disorders like attention-deficit/hyperactivity disorder (ADHD), schizophrenia, and autism spectrum disorder.

Magnesium is a popular supplement for supporting sleep. The mineral can help relax you and regulate your circadian rhythm (your body’s sleep and wake cycle). The mineral may also help improve sleep quality and reduce daytime sleepiness, snoring, and waking up at night.

The daily upper limit for magnesium in dietary supplements and medications is 350 milligrams (mg), not including magnesium naturally found in food.

Side effects associated with taking too much magnesium include diarrhea, nausea, abdominal pain, irregular heartbeat, and cardiac arrest. The risk for side effects is higher in people with kidney disease.

Magnesium supplements may interact with medications like:

  • Bisphosphonates: These drugs treat osteoporosis. Magnesium can decrease the absorption of these medications, so take magnesium and bisphosphonates at least two hours apart.
  • Antibiotics: Taking magnesium with certain antibiotics, such as doxycycline and ciprofloxacin, can decrease the absorption of the antibiotic. Take antibiotics two hours before or four to six hours after a magnesium supplement. 
  • Diuretics: Potassium-sparing diuretics, such as Aldactone (spironolactone), may decrease the amount of magnesium that gets excreted through your urine. If you take a magnesium supplement with a diuretic, it may raise your magnesium levels too high.
  • Zinc: Very high doses of zinc may interfere with your body’s ability to absorb magnesium.

Magnesium is a mineral involved in many body processes, and may benefit your health in a variety of ways, such as supporting your cardiovascular system, reducing insomnia, and easing constipation.

Your body does not make magnesium on its own, so you must get it through food or supplements.



Source link

22 09, 2025

XRP Price Prediction Capped, DeepSnitch AI Buyers Chase 500x

By |2025-09-22T22:08:42+03:00September 22, 2025|Crypto News, News|0 Comments

Disclaimer: This is a Press Release provided by a third party who is responsible for the content. Please conduct your own research before taking any action based on the content.


PayPal just widened its footprint in crypto. The payments giant announced that its PYUSD stablecoin is now expanding across eight new blockchains. The move, powered by LayerZero’s Stargate Hydra bridge, makes PYUSD one of the most accessible stablecoins in the market today.

Nevertheless, people who want the next 100x project to add to their portfolios are focusing on small tokens. Cryptos with a low entry but with the potential to increase their value by hundreds.

That’s why the attention is locked on presales, and DeepSnitch AI is the one buyers are saying could be the breakout regret of the year if ignored. Demand is at its peak, with more than $226,000 raised despite being in stage 1 of its presale.

PayPal expands PYUSD to other blockchains

The expansion of PYUSD shows how quickly stablecoins are becoming an important infrastructure in crypto. By launching a permissionless version of PYUSD, dubbed PYUSD0, PayPal is making its stablecoin fungible and interoperable across multiple chains.

The integration will run through LayerZero’s Stargate Hydra, allowing minting, burning, and deployment across Tron, Avalanche, Aptos, Sei, Abstract, and others. At the same time, PYUSD has gone live on Stellar, adding to its existing support on Ethereum, Solana, and Arbitrum.

The strategy is simple for PayPal. It wants to plant PYUSD everywhere. But for the average crypto user, the attention is elsewhere, focusing on coins that can still multiply by large amounts. DeepSnitch AI sits firmly in that conversation.

Top tokens to watch: XRP price predictions as DeepSnitch AI sells out fast

DeepSnitch AI holders could see $100 turning into $100k or more

Most AI coins pitch broad infrastructure concepts like data marketplaces or compute networks, stories too abstract for everyday users. DeepSnitch AI takes a different path. Its five AI-driven agents are designed to provide actionable insights in real-time: scanning wallets, detecting scams, and delivering faster signals. It’s practical, usable, and it hits the exact pain points people deal with every day.



The AI market is expected to expand 25x by 2033, and nearly half of crypto holders expect AI tokens to dominate by 2025. Waiting on the sidelines could mean missing the few projects that actually matter. DeepSnitch AI is one of the few that are best positioned to benefit from this expansion. Those who hesitate to get into these crypto projects risk watching the best entry points vanish.

Then comes the asymmetric upside. Large-cap tokens like XRP or SEI can no longer deliver 100x gains without reaching valuations larger than entire economies. DeepSnitch AI is still early. With entry-level pricing and a fresh presale, even small inflows can lead to serious returns. This is why urgency is mounting because presales like this don’t stay cheap for long.

What’s causing the fear of missing out is how quickly things can move. Stage 1 has already crossed the $222,000 mark, with tokens priced around 10% higher than launch.

Every new stage pushes the price further, so the energy around DeepSnitch AI is building fast.

 

 

XRP price predictions

XRP has been making progress of its own. Vivopower International Plc announced a partnership with Confirmo to use XRP-powered rails for payroll and treasury payments, aiming to reduce costs and cut delays.

XRP Price Prediction Capped, DeepSnitch AI Buyers Chase 500x

The market response has been muted. XRP slipped slightly over the past week, down 0.2% to $3.04, underperforming the market. Still, XRP price predictions remain bullish, with analysts projecting a rise to $3.52 by December. For XRP, the ETF debut alongside Dogecoin earlier in the week adds legitimacy. But it is now more of an institutional project because its market size is already in the hundreds of billions.

SEI price outlook

SEI has also been tied into PayPal’s PYUSD expansion. The blockchain was among the new networks tapped for PYUSD0 integration through Stargate Hydra, a milestone that shows its growing role in stablecoin infrastructure.

Market performance has been average. Sei is up 1.6% on the week, outperforming the market but lagging other smart contract platforms. Analysts expect a drop to $0.25 by October 18.

DeepSnitch AI: Don’t miss the next crypto to explode

DeepSnitch AI is being talked about as the kind of presale that makes cycles a successful one. It combines branding that can go viral with AI tools that solve real problems, offering an entry point that is still early enough to matter. Considering the wider AI market is set to increase by 25x, the massive demand feels justified.

Stage 1 is open now, and the price has already increased by about 10%.

DeepSnitch AI is carrying the FOMO energy right now.

 

Visit the official DeepSnitch AI site today and explore the presale details.

FAQs

How much has DeepSnitch AI raised so far?

Over $222,000 has been raised in Stage 1, with tokens already about 10% above their launch price.

Can XRP price predictions deliver the same returns as DeepSnitch AI?

No. XRP has scale and adoption, but its size is already big for massive growth. DeepSnitch AI is still small enough for huge multiples.

What makes DeepSnitch AI different from other AI coins?

It doesn’t pitch vague infrastructure. Instead, it delivers tools that can be used to filter scams and detect flows faster.

Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

/div>

Source link

22 09, 2025

Top 10 dApp Development Companies 2025 Selection Guide

By |2025-09-22T20:32:45+03:00September 22, 2025|News, NFT News|0 Comments


You are not shopping for code. You are buying risk reduction, speed to market, and security. This guide gives you a clear shortlist, selection criteria that map to business outcomes, and concise snapshots of the best dApp development companies in 2025 so you can brief stakeholders and sign a partner without spinning your wheels.

What counts as a great dApp partner in 2025

You want a team that ships audited smart contracts, production UIs, and on-chain integrations without blowing your budget or timeline. Judge vendors on outcomes, not pitches.

Core criteria that actually move the needle:

  • Technical depth across chains. Ethereum, Solana, Polygon, BNB Smart Chain. Rust, Solidity, TypeScript. Cross-chain messaging and oracles.

  • Security first. Independent audit readiness, formal verification where needed, battle-tested libraries, CI on testnets, incident playbooks.

  • Delivery discipline. Discovery, tokenomics, architecture, sprints, QA, audits, launch, post-launch SRE.

  • Real portfolios. DeFi, NFT, gaming, enterprise, supply chain. Ask for active mainnets and TVL or active users where possible.

  • Total cost clarity. Fixed scope, itemized audits, infra estimates, ongoing maintenance.

Benchmarks to request in the proposal:

  • Time to MVP under 90 days for standard scopes.

  • Unit and integration test coverage above 80 percent for core contracts.

  • Named audit partners and a sample report.

  • Playbook for upgrades, governance, and emergency pause.

How dApp development works today

You will pick a chain, define token and governance models, write and test smart contracts, integrate wallets, index on-chain data, and secure the whole thing. Expect:

  • Chain selection tradeoffs. Fees, throughput, tooling, and ecosystem liquidity.

  • Smart contracts. Solidity or Rust with strict linting, fuzzing, and differential testing.

  • Storage. Hybrid design with IPFS or Arweave for assets, event-driven indexers for query speed.

  • Front end. React or Vue with wagmi/viem, WalletConnect, Ledger and Trezor support.

  • Security. Static analysis, property testing, threat modeling, and external audits before mainnet.

  • DevOps. Private keys in HSM, multi-sig deploys, canary releases, and monitoring.

Quick scoring matrix for vendor selection

Weighting that reflects typical enterprise needs:

  • Technical expertise 30%

  • Security and audits 20%

  • Portfolio and case studies 15%

  • Innovation and customization 10%

  • Client reviews and reputation 10%

  • Post-launch support 10%

  • Cost efficiency 5%

Use it as a checklist during demos and reference calls.

The 2025 shortlist: who to call first

Below are concise snapshots to help you filter fast. Use them to build your RFP list and schedule discovery calls.

Rapid Innovation

Best for fast MVPs that still respect security. Strong multi-chain delivery, clear discovery, and a 90-day MVP option that keeps teams accountable. Good fit for startups and enterprises spinning up new business lines.

SemiDot Infotech

Cost-effective builds with blockchain plus AI capability. Solid for small to mid-size projects that need mobile plus Web3.

Bloq

Enterprise consulting and multi-chain infrastructure with deep architecture support. Best if you need strategy, integration, and high-stakes delivery.

RWaltz Group Inc.

Cross-industry experience with Ethereum and Hyperledger. Suits regulated or complex enterprise deployments.

Mobiloitte Inc.

Large bench for large scopes. Good for organizations that want scale across blockchain, IoT, and AI.

Calibraint Technologies

Balanced price to quality with custom builds and attentive PM. Strong where you need tailored UX and steady iteration.

Interexy

Polished UI and NFT marketplace expertise with vertical focus in healthcare and fintech. Choose for consumer-grade UX and design.

  • Location United States, UAE

  • Team size 50–250

  • Rate guide upper mid

  • Standout design systems and mobile craft

EOSIO

Throughput and security focus for high-volume apps. Choose for performance-sensitive enterprise workloads.

ChromaWay

Strong in finance, gaming, and supply chain. Good for tokenized assets and enterprise consortia.

Belitsoft

Custom builds with a consulting mindset, clean delivery, and pragmatic costs. Fits SMB and mid-market buyers.

How to choose the right partner for your scope

If you are building DeFi

  • Demand prior audits on AMMs, staking, lending, or perpetuals.

  • Ask for TVL history, oracle strategy, and liquidation safety checks.

If you are launching an NFT marketplace or gaming project

  • Confirm IPFS or Arweave pipelines, royalties enforcement, anti-fraud, and bot mitigation.

  • Push for device performance baselines and queue handling during mints.

If you are an enterprise with compliance needs

  • Require role-based access, data residency options, SOC 2 or ISO 27001 alignment, and key management in HSM.

  • Get a written incident response plan with contact SLAs.

If you need speed to MVP

  • Fix core scope to one chain.

  • Lock a 12-week timeline with interim demos, testnet launch by week 8, audit window weeks 9–10, mainnet cutover week 12.

Red flags that waste time and money

  • No independent audit partner named.

  • Hand-wavy estimates without a breakdown for front end, contracts, infra, and audits.

  • No clear rollback or pause mechanism in contracts.

  • Single-sig deployment wallets.

  • No uptime, alerting, or on-call commitment post-launch.

Pricing and timelines you can actually use

Typical ranges for a solid build with audits:

  • DeFi MVP with staking and rewards 12–16 weeks

  • NFT marketplace with minting and royalties 10–14 weeks

  • Enterprise supply chain pilot 12–18 weeks

Cost drivers you control:

  • Chain count and cross-chain features

  • Custom tokenomics and governance

  • Audit scope and number of findings to remediate

  • Data indexing and analytics depth

FAQs

What is a dApp
A decentralized application that runs on a blockchain network and uses smart contracts for logic and settlement.

How are dApps different from traditional apps
They run on peer-to-peer networks, remove central control, and rely on cryptography and consensus. Upgrades, data access, and security require different design choices.

Which chain should I pick first
Start where your users and liquidity are. Ethereum for ecosystem depth, Solana for performance, Polygon for cost, BNB Smart Chain for reach.

Do I really need an external audit
Yes. Internal testing is not enough. Budget and schedule for it before mainnet.

How do I vet case studies
Ask for contract addresses, dashboards, or public repos. Verify activity on chain and uptime stats.

What post-launch support matters
Monitoring, key management, emergency procedures, upgrade planning, and SLA-backed incident response.

Book discovery with two vendors from this list. Bring the scoring matrix, a 12-week MVP brief, and your must-have integrations. Pick the team that hits your security bar, proves mainnet experience, and commits to a real schedule with an audit window.



Source link

22 09, 2025

XAU/USD extends record run beyond $3,730

By |2025-09-22T20:26:49+03:00September 22, 2025|Forex News, News|0 Comments


XAU/USD Current price: $3,736.92

  • Financial markets keep digesting the latest Fed decision and dropping the US Dollar as a result.
  • American data spread throughout the week should confirm or deny speculative interest perspectives.
  • XAU/USD is again overbought, but there are no technical signs of upward exhaustion.

Spot Gold keeps rallying to record levels, reaching $3,73 a troy ounce on Monday and holding nearby in the American session. Despite a generalized optimism, demand for the bright metal continues amid broad US Dollar (USD) weakness.

Financial markets are still digesting the latest United States (US) Federal Reserve (Fed) monetary policy announcement. The US central bank lowered the benchmark rate as expected in the September meeting, and hinted at additional cuts in November and December. American data scheduled for this week will help speculative interest confirm or deny their beliefs on the matter.

S&P Global will publish the preliminary estimates of the September Purchasing Managers’ Indexes (PMIs) on Tuesday, anticipated to show business activity expanded at a healthy pace. The final Q2 Gross Domestic Product (GDP) estimate will be out on Thursday, while on Friday, the country will release updated Personal Consumption Expenditures (PCE) Price Index figures, the Fed’s favorite inflation gauge.

XAU/USD short-term technical outlook

The XAU/USD pair is firmly up for a second consecutive day, and technical readings in the daily chart suggest further advances are still in the docket. The Relative Strength Index (RSI) indicator bounced from its 70 line, and maintains a strong upward slope within overbought readings. At the same time, the Momentum indicator consolidates well above its 100 line, lacking directional strength. Finally, the pair runs beyond bullish moving averages, with the closest being the 20 Simple Moving Average (SMA) at around $3,581.

The 4-hour chart for XAU/USD shows technical indicators are partially losing their bullish slopes after reaching overbought readings, still holding within extremes and without signs of changing course. At the same time, the bright metal runs beyond all its moving averages, with a mildly bullish 20 Simple Moving Average (SMA) hovers around $3,674.00, while the 100 and 200 SMAs accelerated north well below the shorter one.

Support levels: 3,724.10 3,707.80 3,691.50

Resistance levels: 3,750.00 3,765.00 3,780.00



Source link

22 09, 2025

EUR/USD, USD/JPY and AUD/USD Forecast – US Dollar Softens a Bit in Early Trading

By |2025-09-22T20:22:58+03:00September 22, 2025|Forex News, News|0 Comments

EUR/USD Technical Analysis

The euro rallied a bit in the early hours here on Monday to reach the 1.18 level. The 1.18 level is a large, round, psychologically significant figure that, of course, has been important multiple times. And if we can break above here, it opens up a move to the 1.19 level, possibly even the 1.20 level. Short-term pullbacks will continue to find plenty of momentum, I think, perhaps trying to break out, but there are a lot of questions out there about the risk appetite, and I think that will continue to be reflected in this pair. If we break down below the 1.17 level, we probably just sit right in that consolidation area for a while.

USD/JPY Technical Analysis

The US dollar initially tried to rally against the Japanese yen, but gave back the gains, and we find ourselves just sitting here. At the 200-day EMA, the Friday candlestick was a hammer. It looks like we might try to form some type of negative shooting star candle. So, I think this is a market that just really doesn’t have anywhere to be at the moment, with the 146 yen level offering support and the 149 yen level offering resistance.

Source link

22 09, 2025

These two popular drinks could help your body fight cancer

By |2025-09-22T20:19:46+03:00September 22, 2025|Dietary Supplements News, News|0 Comments


Green tea and red wine may seem like simple dietary choices – but beneath the surface, they harbour compounds with remarkable medical potential. Scientists are uncovering how these everyday drinks might support cancer treatment, not by replacing conventional therapies like chemotherapy or radiotherapy, but by enhancing their effectiveness and reducing their side effects.

The humble cup of green tea, first enjoyed in first-century China, has long been valued for its cultural significance and traditional health benefits. Tea has historically been used to combat ageing, protect the brain and heart, and aid weight loss.

Today, researchers are uncovering a more profound capability – its potential to fight cancer.

The key lies in epigallocatechin gallate (EGCG), a potent antioxidant found in this kind of tea. Antioxidants are protective molecules that help shield cells from damage caused by free radicals and environmental stress, but EGCG appears to do much more.

Tea has historically been used to combat ageing, protect the brain and heart, and aid weight loss (Getty/iStock)

Cancer cells are notoriously disruptive, hijacking the body’s normal energy systems to fuel their rapid growth. EGCG targets this very process, disrupting how cancer cells generate energy, and attacking the proteins that help tumours grow and divide. By targeting these proteins, it prevents cancer from multiplying, ultimately leading to cell death.

Even more promising is EGCG’s ability to enhance conventional treatments. Early studies suggest it could make cancer cells more vulnerable to chemotherapy and radiation therapy, potentially reducing the need for high doses and their severe side effects.

For those who prefer their green tea in powdered form, matcha offers even greater protection, as it’s made from whole ground tea leaves and contains significantly more EGCG than regular green tea.

Red wine’s protective power

Red wine, too, offers compelling potential, thanks to a substance called resveratrol. This compound is found in red grapes, blueberries and peanuts, and has been shown to support the heart, liver and brain. Interestingly, resveratrol works through mechanisms distinct from EGCG.

About the authors

Ahmed Elbediwy is a Senior Lecturer in Clinical Biochemistry and Cancer Biology at Kingston University.

Nadine Wehida is a Lecturer in Genetics and Molecular Biology at Kingston University.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Rather than targeting cancer cells directly, resveratrol focuses on the tumour’s environment. Cancer cells cleverly surround themselves with blood vessels and supportive tissue, creating a protective fortress that aids growth and spread. Resveratrol disrupts this structure, making tumours vulnerable to conventional treatments.

The compound also enhances the immune system’s ability to recognise and attack cancer cells more effectively. Perhaps most significantly, resveratrol prevents tumours from forming new blood vessels – the lifelines they need to obtain nutrients for growth. Without this blood supply, tumours become starved and eventually die.

Beyond the glass

The potential of natural cancer-fighting compounds extends far beyond our favourite beverages. Apigenin, found in parsley, can slow tumour growth, while turmeric contains curcumin, which disrupts cancer-cell survival. And emodin, found in aloe vera and rhubarb, reduces inflammation and inhibits cancer growth.

However, scientists face a significant challenge: many of these natural substances are poorly absorbed by the body. Research in this area is currently focused on developing enhanced delivery systems, such as wrapping the compounds in tiny lipids called nanoparticles. This approach protects the substances and increases their effectiveness against tumours.

These two popular drinks could help your body fight cancer

These everyday drinks would not replace conventional therapies like chemotherapy or radiotherapy (Getty/iStock)

The absorption of natural substances is further improved by mixing compounds with each other, such as piperine with curcumin. Piperine is found in black pepper and helps curcumin-based nanoparticles to have better bioavailability in cancer therapy.

While the research remains in its early stages, the possibility that everyday foods and drinks could one day support cancer treatment represents a fascinating frontier in medical science.

So the next time you reach for a cup of green tea or a glass of red wine, consider this: you may be doing more than relaxing – you could be reinforcing your body’s natural defences against cancer.



Source link

22 09, 2025

Could DOGE Price Hit $1 In 2026?

By |2025-09-22T20:06:27+03:00September 22, 2025|Crypto News, News|0 Comments

Dogecoin is once again in the spotlight. A lot of traders are watching whether the Dogecoin price can climb to $1 by 2026. Currently trading around $0.266, DOGE has seen mixed short-term performance but continues to attract attention due to its large market cap and dedicated community. At the same time, Remittix (RTX) is emerging as a top alternative for investors seeking real-world use and high growth potential.

Dogecoin Price Prediction: $1 in 2026

Could DOGE Price Hit  In 2026?

The price of Dogecoin is at the moment standing at $0.26647. The coin currently occupies the 8th place in the entire cryptocurrency market. DOGE is currently circulating 151 billion coins with a market capitalisation of more than 40 billion. 

Although Dogecoin has drawn some attention lately, it has performed poorly in the short term. In the last seven days, DOGE has decreased by approximately 7.03%. But in the last month, the token has increased by 20.67%, which supports the prospects of an increase. The traders are currently keen on whether Dogecoin will sustain the pace and rise to the top of $1 in 2026.

Analysing technical information, analysts predict that the price of DOGE will be between $0.218 and $0.275 within the near future, with an average price point being $0.332. By October 2025, it is estimated that Dogecoin will go around $0.287, although it has a range of $0.241 to $0.332 during changes in the market. The trend is positive, which is why analysts are confident that the DOGE price can reach one dollar in 2026.

Why Remittix Could Outperform Meme Coins

While Dogecoin continues to draw attention, emerging tokens like Remittix (RTX) are gaining traction for their real-world utility and strong growth potential. Remittix is capturing investor interest by offering innovative cross-border PayFi solutions and a robust ecosystem. 

With early CEX listings, beta wallet testing, and a transparent roadmap, Remittix is being positioned as a top choice for investors seeking high returns in the current altcoin market.

Here’s why analysts are highlighting Remittix:

  • Current Price: $0.1130, representing a low-cost entry point for early investors.
  • Token Milestones: Over 668 million tokens sold, reflecting strong market interest.
  • CEX Listings: Secured on BitMart and LBANK, with a third exchange in preparation.
  • CertiK Verification: Ranked #1 among pre-launch tokens, ensuring trust and security.

Conclusion

In the next few months, the Dogecoin price may stay between $0.35 and $0.40. Analysts believe the gains will be moderate in the long-term to 2025 and 2026. Nevertheless, the fact that the coin is subject to hype by the community and temporary emotion constrains its chances of becoming a far-fetched phenomenon.

By contrast, Remittix offers tangible utility, verified security, and active product development, positioning it as a strong contender for substantial returns. Investors considering a balanced approach to altcoins might look at both DOGE for meme-driven momentum and Remittix for real-world growth potential.

Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/ 

Socials: https://linktr.ee/remittix

$250K Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Source link

22 09, 2025

XAU/USD at fresh record highs, aims for $3,730 and $3,760

By |2025-09-22T18:25:44+03:00September 22, 2025|Forex News, News|0 Comments


  • Gold hits fresh record highs above $3,720 on cautious markets amid geopolitical tensions.
  • The next potential targets are $3,730 and $3,760.
  • The technical picture shows overbought conditions, daily RSI suggest incipient bearish divergence.

Gold bounced up from the $3,630 area on Friday and is extending gains on Monday, supported by a cautious market mood and hopes of further Fed easing. The precious metal is trading at $3,720, with the following potential targets at $3,730 and $3,760.

The fundamental backdrop remains supportive. European markets have opened on a moderately negative note, as tensions remain high between Russia and its European partners, while in the Middle East, Israel’s occupation of Gaza is generating an increasing wave of opposition among Western countries.

Technical Analysis: Gold is strongly bullish but looks overextended

 

The technical picture, on the other hand, is sending warning messages. The daily chart shows the pair at overbought levels, after having rallied more than 12% in one month. RSI is starting to suggest some bearish divergence, and the MACD shows an impending bearish cross, which should warn buyers.

On the upside, immediate resistance is the <27.2% Fibonacci retracement of last week’s pullback, at $3,730, ahead of the 161.8% retracement of the same cycle, at $3,760. Beyond here, the $3,800 round level emerges as a potential target.

To the downside, the previous all-time high, at $3,707, might provide support ahead of the $3,615-3,630 area (September 11, 18 lows). Further down, the September 3 high and September 8 low, at $3,580, would come into focus.

Gold FAQs

Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.

Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.

Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.

The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.



Source link

22 09, 2025

Euro finds support ahead of central bank speeches

By |2025-09-22T18:21:50+03:00September 22, 2025|Forex News, News|0 Comments

  • EUR/USD clings to small daily gains above 1.1750 on Monday.
  • The technical outlook doesn’t yet point to a buildup of bullish momentum.
  • Markets await comments from ECB and Fed policymakers.

Following the bearish action seen in the second half of the previous week, EUR/USD corrects higher on Monday and trades above 1.1750. As investors await comments from central bank officials, the pair’s technical outlook doesn’t yet reflect a buildup of recovery momentum.

Euro Price Last 7 Days

The table below shows the percentage change of Euro (EUR) against listed major currencies last 7 days. Euro was the weakest against the Swiss Franc.

USD EUR GBP JPY CAD AUD NZD CHF
USD -0.24% 0.42% 0.16% -0.23% 0.75% 1.58% -0.27%
EUR 0.24% 0.69% 0.35% 0.00% 1.03% 1.78% -0.04%
GBP -0.42% -0.69% -0.26% -0.67% 0.34% 1.09% -0.83%
JPY -0.16% -0.35% 0.26% -0.41% 0.63% 1.41% -0.43%
CAD 0.23% -0.01% 0.67% 0.41% 1.09% 1.77% -0.16%
AUD -0.75% -1.03% -0.34% -0.63% -1.09% 0.75% -1.09%
NZD -1.58% -1.78% -1.09% -1.41% -1.77% -0.75% -1.90%
CHF 0.27% 0.04% 0.83% 0.43% 0.16% 1.09% 1.90%

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Euro from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent EUR (base)/USD (quote).

EUR/USD registered losses for three consecutive days to end the week as the US Dollar (USD) benefited from the Federal Reserve’s cautious tone on aggressive policy easing moving further.

Assessing the Fed’s policy outlook and the USD’s futures, “despite Fed Chair Jerome Powell’s cautionary tone, the FOMC has clearly shifted to a dovish stance where it sees multiple cuts, and the focus is now firmly on the employment side of the mandate,” noted ING analysts and added:

“Our call is for two more 25 basis-points cuts this year, and we see the cheapening of the Dollar’s funding cost as driving more depreciation in an already seasonally weak end of the year for the greenback.”

The US economic calendar will not feature any high-tier data releases on Monday. Several Fed policymakers will be delivering speeches during the American trading hours. In case Fed officials reiterate that they will not commit to a steady easing of the policy, citing upside risks to inflation, the USD could stay resilient against its rivals and make it difficult for EUR/USD to gather bullish momentum.

European Central Bank (ECB) Chief Economist Philip Lane and Governing Council Member Joachim Nagel will also be speaking in the second half of the day. ECB policymaker Mario Centeno said on Friday that the ECB’s next move is likely to be a rate cut, noting that he still sees inflation risks to the downside. Similar remarks from ECB officials could be negative for the Euro with the immediate reaction.

EUR/USD Technical Analysis

The Fibonacci 23.6% retracement of the latest uptrend aligns as a pivot level at 1.1770. In case EUR/USD fails to clear this level, technical buyers could be discouraged. In this scenario, 1.1730 (100-period Simple Moving Average (SMA) on the 4-hour chart) could be seen as the first support level before 1.1690-1.1700 (Fibonacci 38.2% retracement, 200-period SMA) and 1.1640 (Fibonacci 50% retracement).

Looking north, resistance levels could be spotted at 1.1800 (static level, round level), 1.1850 (upper limit of the ascending channel) and 1.1870 (end-point of the uptrend).

Euro FAQs

The Euro is the currency for the 19 European Union countries that belong to the Eurozone. It is the second most heavily traded currency in the world behind the US Dollar. In 2022, it accounted for 31% of all foreign exchange transactions, with an average daily turnover of over $2.2 trillion a day.
EUR/USD is the most heavily traded currency pair in the world, accounting for an estimated 30% off all transactions, followed by EUR/JPY (4%), EUR/GBP (3%) and EUR/AUD (2%).

The European Central Bank (ECB) in Frankfurt, Germany, is the reserve bank for the Eurozone. The ECB sets interest rates and manages monetary policy.
The ECB’s primary mandate is to maintain price stability, which means either controlling inflation or stimulating growth. Its primary tool is the raising or lowering of interest rates. Relatively high interest rates – or the expectation of higher rates – will usually benefit the Euro and vice versa.
The ECB Governing Council makes monetary policy decisions at meetings held eight times a year. Decisions are made by heads of the Eurozone national banks and six permanent members, including the President of the ECB, Christine Lagarde.

Eurozone inflation data, measured by the Harmonized Index of Consumer Prices (HICP), is an important econometric for the Euro. If inflation rises more than expected, especially if above the ECB’s 2% target, it obliges the ECB to raise interest rates to bring it back under control.
Relatively high interest rates compared to its counterparts will usually benefit the Euro, as it makes the region more attractive as a place for global investors to park their money.

Data releases gauge the health of the economy and can impact on the Euro. Indicators such as GDP, Manufacturing and Services PMIs, employment, and consumer sentiment surveys can all influence the direction of the single currency.
A strong economy is good for the Euro. Not only does it attract more foreign investment but it may encourage the ECB to put up interest rates, which will directly strengthen the Euro. Otherwise, if economic data is weak, the Euro is likely to fall.
Economic data for the four largest economies in the euro area (Germany, France, Italy and Spain) are especially significant, as they account for 75% of the Eurozone’s economy.

Another significant data release for the Euro is the Trade Balance. This indicator measures the difference between what a country earns from its exports and what it spends on imports over a given period.
If a country produces highly sought after exports then its currency will gain in value purely from the extra demand created from foreign buyers seeking to purchase these goods. Therefore, a positive net Trade Balance strengthens a currency and vice versa for a negative balance.

Source link

22 09, 2025

How supplement labels trick consumers into believing health claims

By |2025-09-22T18:18:42+03:00September 22, 2025|Dietary Supplements News, News|0 Comments


A new study reveals that much of the confidence people have in the health benefits of supplements might not come from science, but from clever wording on labels. Phrases like “boosts brain function” are enough to make consumers believe that a supplement can prevent serious conditions like dementia.

According to a 2023 survey, three-quarters (74%) of Americans report taking dietary supplements, with a staggering 92% of users saying that they’re essential to maintaining their health. But how essential are they, really? And how convincing?

A new study led by the University of Texas Southwestern Medical Center has examined how commonly made claims, such as “supports heart health” or “supports brain health,” affect our beliefs regarding the health benefits of dietary supplements.

Under US Food and Drug Administration (FDA) regulations, three types of label claims are allowed on dietary supplements: nutrient claims, health claims, and structure/function claims. Nutrient claims refer to how much of an ingredient is in a supplement (e.g., “only 200 mg of sodium”). Health claims refer to any statement associating a supplement ingredient with the treatment or prevention of a specific disease. They’re based on evidence reviewed by the FDA and are relatively rare. Structure/function claims are meant to highlight the effect of a supplement ingredient on normal body function (e.g., “calcium builds strong bones”). The problem is, though, that these sorts of claims can use language that’s ambiguous, including phrases like “heart health” or “brain health”.

The researchers ran two online surveys of US adults. Survey one gauged 2,239 participants’ beliefs in relation to fish oil supplements, a real and widely used product. For survey two, the researchers created a completely made-up supplement – they called it “Viadin H” – to see whether labeling affected the preexisting beliefs of 2,164 participants. Each participant was randomly shown one of four labels for the supplement, which varied only in the type of health-related claim: “Supports Heart Health”, “Supports Cognitive Function”, “Brain Health”, or no claim at all. After viewing the label, participants answered whether they thought the supplement could prevent or treat diseases like heart attack, heart failure, stroke, dementia, osteoporosis, or cancer.

A completely made-up supplement was believed to prevent heart attacks because of its label claims

Firefly 3

For the fish oil supplement, people shown the “Supports Heart Health” label were more likely than those shown a label with no claims to say the supplement prevented heart attacks (62.5% vs 53.9%) or heart failure (59.0% vs 50.7%). Those shown the “Supports Cognitive Function” label claim were more likely to report that fish oil prevents dementia (47.4% vs 39.6%) and improves memory in people with dementia (48.0% vs 40.5%).

For the hypothetical Viadin H, the labels had an even bigger effect, since participants couldn’t have had any prior beliefs about health benefits. Those shown a label that read “Heart Health” or “Supports Heart Function” were more likely to report that the supplement prevents heart attack or heart failure: 40.0% and 40.5% for each respective label. In contrast, those shown brain health-related labels and more likely to report that the supplement prevents dementia or improves memory were lower: 20.2% for the “Brain Health” label, and 23.3% for “Supports Cognitive Function”. For the control conditions of osteoporosis and cancer, labels didn’t significantly change perceptions for unrelated conditions.

The study has limitations. Principally, it was a survey about people’s perceptions, not whether they actually bought or used the supplements differently. There is the potential for issues using self-reporting because participants can choose answers at random or give responses they think are “expected.”

Regardless, the findings raise some interesting – and important – issues. By law, structure/function claims, such as “Supports Heart Health”, aren’t supposed to imply disease prevention or treatment. Yet, the study shows that many consumers interpret them that way. The study authors argue that these statements should be reclassified as health claims, which would require scientific evidence and FDA review. They said this would reduce consumer misunderstanding.

The study was published in the journal JAMA Network Open.





Source link

Go to Top